The mission of the ISCIII Biobanks and Biomodels Platform is to offer the highest level of quality and cutting-edge services to facilitate and advance in the definition of better therapy for the patient and thereby close the cycle from basic research to the execution of the clinical application. The vision of the  Platform is to become a national and international model for companies, clinical institutions, and research and administrative bodies as an infrastructure able to perform, from a scientific, technological and regulatory perspective, a complete preclinical validation which ranges from the design to the validation of the product in vivo.

Data collection started in 2009.